Needle Biopsy Market Share

Global Needle Biopsy Market overview

The Needle Biopsy Market Size was valued at USD 1.33 Billion in 2023. The Global Needle Biopsy industry is projected to grow from USD 1.47 Billion in 2024 to USD 3.04 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.42% during the forecast period (2024 - 2032). Needle biopsy is a process that involves inserting a needle into the proper sampling location to remove a sample of cells from the body. The removed tissue is then tested in a laboratory to see whether there are any abnormalities. A needle biopsy is typically performed to diagnose symptoms such as a tumor or lump, inflammation, or infection. For more exact findings, computed tomography or ultrasound are sometimes used in conjunction with a needle biopsy. Market limitations include the development of ultrasensitive imaging technologies such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and others. The development of liquid biopsy, on the other hand, is the single greatest danger to suture needle biopsy's future.

A Needle Biopsy is a technique that involves inserting a needle into the proper sampling location to remove a sample of cells from the body. The tissue is then tested in the lab to see whether there are any abnormalities. Because of market drivers such as malignancies and infections, the needle biopsy market is increasing. The rising prevalence of breast and lung cancer is one of the major factors predicted to drive the needle biopsy market's growth and demand. Furthermore, the fast rise in demand for minimally invasive operations, as well as numerous initiatives made by governments and worldwide health organizations, are expected to drive development in the needle biopsy market from 2024 to 2032. Similarly, fast technical improvement and development, as well as increased awareness about early diagnosis of breast cancer, are expected to drive market expansion.

This report contains all the information on the needle biopsy market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the global needle biopsy industry analysis and forecast for 2030 is also included in the report.

Covid 19 Analysis

The Needle Biopsy market study analyses the Covid-19 limitations put on business owners, investors, and others. The geographical and regional impacts fluctuate often due to the fact that locks are done differently in different areas and nations. This research examines current market effects in the short and long term, assisting decision-makers in developing short and long-term company plans across geographies.

Needle Biopsy Market Trends

•         Drivers

The needle biopsy market is primarily driven by product production and the decrease in raw material and component prices. Rising cancer incidence and the increased usage of biopsy needles are driving market development. Companies should focus on increasing distribution quality to alleviate pricing pressures caused by enormous market fragmentation. Distribution agreements between large players and new items, such as multi-layer needles, would be extremely advantageous. The growing worldwide elderly populations, as well as government initiatives to raise cancer awareness, are projected to drive kidney biopsy market growth.

•         Opportunities

The introduction of needle biopsy and promising clinical studies, as well as an improved reimbursement environment, are projected to provide substantial growth opportunities for the needle biopsy market from 2021 to 2028.

•         Restraints

The needle biopsy market is currently restricted by the rapid development of ultrasensitive imaging technologies such as magnetic resonance imaging (MRI) and computed tomography (CT) as well as product recalls

•         Challenges

The needle biopsy market is expected to be challenged by the underdeveloped healthcare infrastructure and lack of resources in developing countries.

Cumulative Growth Analysis

According to the Our World in Data Organization, breast cancer is the most common type of cancer, with an estimated 17 million individuals diagnosed with the disease in 2017. According to the source, around 2 million new instances of breast cancer were recorded globally in 2018. Breast cancer is the second largest cause of cancer-related deaths among women worldwide, according to the American Cancer Society. Furthermore, according to the aforementioned source, one in every eight women in the United States has invasive breast cancer throughout her lifetime.

Similarly, according to the Canadian Cancer Society, on average, 72 women were diagnosed with breast cancer in Canada per day in 2017, while 14 women died from cancer every day. As a result, the demand for and utility of needle biopsy devices market would expand, aiding the needle biopsy market growth.

Value Chain Analysis

According to the reports, the global needle biopsy market is segmented on the basis of types, applications, and regions. The market has been divided into four types: fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, and image-guided biopsy. The market has been divided into two categories based on utility: disposable and reusable. The market has been divided into applications such as a tumor, infection, inflammation, and others.

Fine aspiration needle biopsy and needle core biopsy are the two most common types of needle biopsies. A hollow needle measuring 11 to 18 gauge is used to remove a sample of tissue from the liver, breast, prostate, and other organs during a core biopsy needle. The area is numbed with local anesthetic until the tissue sample is taken. To get only a little piece of the injured region, fine needle aspiration biopsy generally requires a small hollow needle ranging from 22–27 gauge. Thyroid samples are most often processed via fine needle biopsy. The vacuum-assisted aspiration and biopsy needle market are projected to be the fastest expanding. Rising cancer screening rates throughout the world would boost the industry. Breast cancer is predicted to be the most often used form of cancer for a needle biopsy.

Needle Biopsy Market Segment Insights

The market is segmented on the basis of types, applications, and regions. The needle biopsy market is expected to witness decent growth during the forecast period.

Needle Biopsy Application Insights

Based on the application, the market is segmented into tumor, infection, inflammation, and others.

Needle Biopsy End-users Insights

Based on the propulsion types, the needle biopsy market is segmented into fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, and image-guided biopsy.

Needle Biopsy Regional Insights

According to the reports, on the basis of regions, the needle biopsy market is divided into North America, Europe, Asia Pacific, Latin America, and the middle east & Africa (MEA). The United States has the largest needle biopsy market share due to attractive reimbursement situations and higher healthcare spending. The speedier market adoption of new technologies in the United States is also a significant driver of the needle biopsy market. Due to high spending money and growing awareness, Europe is the second-largest market. Because of huge unmet demands, the Asia Pacific area is the fastest expanding, headed by China and India. The Gulf countries, notably Saudi Arabia and the United Arab Emirates, dominate the Middle East and Africa markets. Due to poor economic and political situations, as well as low healthcare penetration, Africa's impoverished areas are anticipated to lag.

Needle Biopsy Market Competitive landscape

Many players are targeting needle-based biopsy guns as a lucrative approach. Fine needle aspiration biopsy is less efficient and detectable than a core needle biopsy. The use of core needle biopsy in conjunction with needle aspiration biopsy to obtain maximum sensitivity and detectability is becoming more common. As a result, the two tests are complementary, and when both tests are run simultaneously, the efficiency rate is greatest.

Major Key Players

• Boston Scientific Corporation


• Cook Medical


• CareFusion Corporation


• Hologic, Inc


• Cardinal Health, Inc.


• Medax


• C. R. Bard, Inc.


• Möller Medical GmbH


• Becton, Dickinson and Company


• Hakko co. ltd.


• Kompass


• Argon Medical Devices, Inc.


• others

Report Overview

The following report comprises of –

•         Market overview 


•         Covid 19 Analysis


•         Market Dynamic


•         Drivers


•         Opportunities


•         Restraints 


•         Challenges


•         Cumulative Growth Analysis


•         Value Chain Analysis


•         Segmentation Overview 


•         By Application 


•         By End-Users


•         Regional Analysis


•         Competitive landscape

Recent Developments

In 2017, an average of 72 women were diagnosed with breast cancer in Canada every day, according to the Canadian Cancer Society, while 14 women died of cancer each day. As a result, demand for and utility of needle biopsy would increase, assisting needle biopsy market growth.

Needle Biopsy Market Segmentation

Needle Biopsy Type Outlook 

• Core Needle Biopsy


• Fine- Needle Aspiration Biopsy


• Vacuum-Assisted Biopsy


• Image-Guided Biopsy

Needle Biopsy Utility Outlook

• Disposable


• Reusable

Needle Biopsy Application Outlook

• Tumor


• Infection


• Inflammation


• Others

Needle Biopsy Regional Outlook

• North America
  
  
  
  • The U.S.
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • France
  
  
  • The UK
  
  
  • Spain
  
  
  • Germany
  
  
  • Italy
  
  
  • Rest of Europe
  
  
  
  


• Asia Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • South Korea
  
  
  • Southeast Asia
  
  
  • Rest of Asia Pacific
  
  
  
  


• Latin America
  
  
  
  • Brazil
  
  
  • Mexico
  
  
  • Rest of Latin America
  
  
  
  


• Middle East & Africa


• GCC


• South Africa


• Rest of Middle East & Africa